文献速递疝与腹壁外科围术期管理与 ERAS

腹膜前腹壁疝修补术:十年以上前瞻性观察研究及1023例患者结局分析

Preperitoneal Ventral Hernia Repair: A Decade Long Prospective Observational Study With Analysis of 1023 Patient Outcomes.
PubMed 文献 · Ann Surg · 2020-01-01

该研究前瞻性观察了2004年1月至2016年4月间1023例开放腹膜前腹壁疝修补术(PP-VHR)的结局。结果显示,尽管患者复杂(68.7%复发疝、43.6%需组织分离),总体疝复发率仅5.2%,合成补片修补为3.9%;但伤口并发症发生率达27.3%,补片感染率1.7%。多因素分析表明,糖尿病、腹壁整形术和生物补片是伤口并发症的预测因素,而复发疝修补、生物补片和伤口并发症是疝复发的预测因素。

要点

  • 开放PP-VHR用于复杂、复发疝修补术后总复发率低(5.2%),合成补片者仅3.9%。
  • 伤口并发症常见(27.3%),糖尿病、腹壁整形术和生物补片增加其风险。
  • 生物补片、复发疝修补及伤口并发症是疝复发的独立预测因素。

核心结论

  • 开放腹膜前腹壁疝修补术是修复大型、复杂和复发疝的有效方法,复发率低。
  • 补片选择与疝复发和伤口并发症相关,在该人群中生物补片预示更差结局。

研究设计与样本

  • 前瞻性观察性研究,纳入2004年1月至2016年4月所有接受PP-VHR的患者,共1023例。
  • 采用多因素逐步logistic回归和Cox比例风险模型分别分析伤口并发症和疝复发的预测因素。

主要发现

  • 患者平均年龄57.2±12.6岁,BMI 33.7±11.4 kg/m,缺损大小210.0±221.4 cm;23.7%有糖尿病,13.9%吸烟,68.7%为复发疝,23.6%为嵌顿疝。
  • 43.6%需组织分离,30.0%行腹壁整形术。
  • 伤口并发症发生率27.3%,补片感染率1.7%。
  • 平均随访27.0±26.4个月,总疝复发53例(5.2%),合成补片修补中复发36例(3.9%)。
  • 多因素分析显示,伤口并发症预测因素包括糖尿病(OR 1.9,95%CI 1.4-3.0)、腹壁整形术(OR 2.6,95%CI 1.8-3.9)和需生物补片的手术(OR未提供);疝复发预测因素包括复发疝修补(HR 2.69,95%CI 1.14-6.35)、生物补片(HR 3.1,95%CI 1.67-5.75)和伤口并发症(HR 3.01,95%CI 1.69-5.39)。

临床怎么用

  • 开放PP-VHR可作为大型、复杂和复发腹壁疝的有效修复术式,但需警惕伤口并发症。
  • 对合并糖尿病、需腹壁整形术或使用生物补片的患者应加强伤口管理以降低并发症风险。
  • 补片选择需权衡:生物补片与更高的疝复发和伤口并发症风险相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to examine the outcomes of over a decade's experience utilizing preperitoneal ventral hernia repair (PP-VHR). BACKGROUND: PP-VHR was first described by our group in 2006, and there have been no subsequent reports of outcomes with this technique. METHODS: A prospective study of all PP-VHR from January, 2004 to April, 2016 was performed. Multivariate stepwise logistic regression and Cox proportional-hazard models were used to identify predictors of wound complications and hernia recurrence, respectively. RESULTS: There were 1023 PP-VHRs. Mean age was 57.2 ± 12.6 years, BMI 33.7 ± 11.4 kg/m, defect size 210.0 ± 221.4 cm; 23.7% had diabetes, 13.9% were smokers, 68.7% were recurrent, and 23.6% incarcerated. Component separation was required in 43.6%, and a panniculectomy was performed in 30.0%. Wound complication was present in 27.3% of patients, with 1.7% having a mesh infection. In all, there were 53 (5.2%) hernia recurrences and 36 (3.9%) in the synthetic repairs, with a mean follow-up of 27.0 ± 26.4 months. On multivariate regression (odds ratio or hazard ratio, 95% confidence interval), diabetes (1.9, 1.4-3.0), panniculectomy (2.6, 1.8-3.9), and operations requiring biologic mesh were predictors of wound complications, whereas recurrent hernia repair (2.69, 1.14-6.35), biologic mesh (3.1, 1.67-5.75), and wound complications (3.01, 1.69-5.39) were predictors of hernia recurrence. CONCLUSIONS: An open PP-VHR is a very effective means to repair large, complex, and recurrent hernias resulting in a low recurrence rate. Mesh choice in VHR is important and was associated with hernia recurrence and wound complications in this population.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Heniford BT, Ross SW, Wormer BA, et al. Preperitoneal Ventral Hernia Repair: A Decade Long Prospective Observational Study With Analysis of 1023 Patient Outcomes. Ann Surg. 2020. PMID: 30080725. doi:10.1097/SLA.0000000000002966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。